A lit­tle biotech slaps back at a 'crim­i­nal' short at­tack, vow­ing to pur­sue a pros­e­cu­tion of their case

As short at­tacks go, Biotech Re­search Part­ners’ as­sault on Ap­plied Ther­a­peu­tics’ “cher­ry picked” da­ta and a va­ri­ety of so-called red flags didn’t cause a whole lot of dam­age. Ahead of the Ju­ly 4 hol­i­day, its shares $APLT were dinged and showed signs of quick re­cov­ery.

But that didn’t stop an in­cen­di­ary re­sponse, as the biotech swung in­to ac­tion bright and ear­ly Mon­day morn­ing.

Ap­plied Ther­a­peu­tics ac­cused the au­thors of the short re­port of ma­nip­u­lat­ing graphs and fig­ures, mis­rep­re­sent­ing da­ta and in­clud­ed fac­tu­al mis­rep­re­sen­ta­tions — all of which added up, in their view, to fraud.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER